Glucagon-Like Peptide-1 Receptor Agonists: What's the Optimizing Policies for Obesity-Related Metabolic Diseases?

ABSTRACT:

SUBMITTER: Park TS 

PROVIDER: S-EPMC11960206 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature